Company profile · free preview

CVS

CVS · Updated 10/25/2026

Revenue

$402.1B

Fiscal 2025

Net income

$1.8B

Fiscal 2025

Free cash flow

$7.8B

Fiscal 2025

Net cash / (debt)

—

Fiscal 2025

Five-year financials

Fiscal year20252024202320222021
Revenue$402.1B$372.8B$357.8B$322.5B$292.1B
Net income$1.8B$4.6B$8.3B$4.1B$7.9B
Diluted EPS—————
Operating cash flow$10.6B$9.1B$13.4B$16.2B$18.3B
Free cash flow$7.8B$6.3B$10.4B$13.4B$15.7B
Cash$8.5B$8.6B$8.2B$12.9B$9.4B
Total debt—————

Where the cash went

Cumulative, fiscal 2021–2025, straight from the reported cash-flow statements.

Reinvested in capex

20.5%

of operating cash flow

Returned to owners

—

of free cash flow (buybacks + dividends)

Diluted share count

—

change 2021–2025

Capital expenditure $13.9BBar width = share of $67.6B operating cash flow
Operating cash flow$67.6B
Capital expenditure($13.9B)
Free cash flow$53.7B
Share buybacks—
Dividends paid—
Acquisitions (net)—
Net debt issued / (repaid)—
Stock-based compensation (non-cash)—

"—" means a year didn't report that line, so no total is shown rather than an estimate.

SEC filings

  • 10-K · period 2025-12-312026-02-10EDGAR

Ask anything about CVS's filings

"What changed since last year?" "Where is the cash going?" Get answers drawn straight from the filings.

Start researching free

More companies